US Congressman welcomes Indias decision to resume export of surplus Covid vaccine


An influential US Congressman has welcomed Indias decision to resume the export of surplus COVID-19 vaccines to meet its commitment to the COVAX global pool.

Indias Health Minister Mansukh Mandaviya on Monday said the country will resume export of surplus COVID-19 vaccines in the fourth quarter of this year under the Vaccine Maitri programme to meet its commitment to the COVAX global pool.

He, however, asserted that vaccinating own citizens remains the topmost priority of the government. COVAX is co-led by Gavi, the Coalition for Epidemic Preparedness Innovations and WHO.

“I welcome todays announcement by the Government of India to resume COVID-19 vaccine exports,” Congressman Gregory Meeks, the chairman of the powerful House Foreign Affairs Committee, said in a tweet on Monday.


“As the worlds leading vaccine manufacturer, Indias role is critical to defeating this pandemic,” Meeks tweeted tagging an article by The New York Times.

India had stopped the export of COVID-19 vaccines after the second wave of the COVID-19 pandemic hit the country in April this year.

(Except for the headline, this story has not been edited by The Federal staff and is auto-published from a syndicated feed.)